Mach One Corporation
Mach One Corporation Expedites Co-Development Plans with PanTheryx for Introduction of Novel Product for Treatment of Pediatric Diarrhea
Published in Drug Week, November 27th, 2009
Mach One Corporation (OTCBB: MNCN), a rapidly growing, innovative, global wellness solutions company, announced that it has completed the first tranche of its investment in PanTheryx, Inc., as stipulated in a recent Letter of Understanding signed in August 2009. This action expedites development and introduction plans for an orally administered antibody therapeutic for treatment of pediatric diarrhea. The co-developed pediatric diarrhea product will initially be targeted for commercial introduction in India, where PanTheryx maintains a sales force and contract sales relationships.
Pediatric diarrhea is an enormous problem in much of the developing world, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-11-27)
More Articles from Drug Week
- American Cancer Society
Breast density associated with increased risk of cancer recurrence - American College of Cardiology
Popular anti-platelet therapy reduces risk of cardiovascular events in men and women - American Thoracic Society
Air pollution increases infants' risk of bronchiolitis - BioMed Central
All dressed-up and nowhere to go - BioMed Central
Perceived parent-pressure causes excessive antibiotic prescription - BioMed Central
The bizarre lives of bone-eating worms - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
